Spinout Active LTD

Company profile

Bioxhale Ltd

Bioxhale

Bioxhale Ltd is a UK company with status active founded in 2021 based in East Midlands.

CRN
13411507
Founded
2021
Age
5

Overview

Browse spinouts
Legal name
BIOXHALE LTD
Region
East Midlands
Registered address
13 SACKVILLE GARDENS
LEICESTER
ENGLAND
LE2 3TH
Insolvency history
No

Latest accounts

Financial period: 1 Jun 2023 to 31 May 2024

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
2

Company events

Reference milestones and recent Companies House filing stream events.

5 events
28 Feb
2027

Accounts due

Accounts Due

Next accounts due date

11 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

27 Jun
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 May
2025

Accounts filed

Accounts

Last accounts made up date

20 May
2021

Incorporated

Inception

Company registered at Companies House

Spinout profile

4 entries

Company description

Bioxhale develops a range of medical breath-testing products for diagnostics.

Delivering Breathomics capacity.

Project impact

Breath analysis services and products under development.

The company has patented technology. It is based in Space park Leicester and has won EU funding.

Bioxhale
2021
Bioxhale
2021
Bioxhale
2021
BIOXHALE LTD
2021

Public funding

4 awards
First funded
2022
Funded years
2022, 2024
Age at first award
1 years

Projects

2024 EU-Funded Lead participant

EMBRACE pan-European Management of Biological toxin incidents through standaRdisAtion initiatives for Crisis response Enhancement

1 Oct 2024 to 30 Sep 2027

Awarded
£239,926
Total cost £239,926

Biotoxins pose significant challenges to current crisis management approaches. Existing concepts of operation, derived from Chemical, Biological, Radiological and Nuclear doctrines, and Union Civil Protection Mechanism initiatives, do not address the distinctive and highly complex attributes of a biotoxin crisis. EMBRACE aims to improve Europe’s capacity ...

2024 EU-Funded Lead participant

HOLISTIC CAPABILITY AND TECHNOLOGY EVALUATION AND CO-CREATION FRAMEWORK FOR UPSKILLED FIRST RESPONDERS AND ENHANCED CBRN-E RESPONSE

1 Jan 2024 to 31 Dec 2026

Awarded
£235,409
Total cost £235,409

Countries worldwide, amid threats and incidents targeting civilians, invest in reinforcing their CBRN-E related capabilities. In Europe and in most cases, the teams responding first are not trained specifically, nor equipped sufficiently to face the kind of hazards, to provide the assistance to victims and to follow the decontamination processes that a CB...

2022 Grant for R&D Lead participant

BreathDraw: a breath analyzer for early disease detection and precision medicine

1 Nov 2022 to 30 Apr 2023

Awarded
£50,000
Total cost £50,000

"Continue to implement the NHS Long Term Plan, focusing on transformation of services, to support NHS resilience, and continue to inspire public confidence" The Government's 2021-22 mandate to NHS England. Our game-changing breath testing technology will help transform healthcare services support our NHS by reducing costs (£1B), appointments/referrals, in...

2022 EU-Funded Lead participant

Fast deployed mobile laboratories to enhance situational awareness for pandemics and emerging infectious diseases: ONELAB

1 Oct 2022 to 30 Sep 2025

Awarded
£173,193
Total cost £247,419

no public description

Product types

EU-Funded Grant for R&D